Begum Horuluoglu
Overview
Explore the profile of Begum Horuluoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Notarnicola A, Hellstrom C, Horuluoglu B, Pin E, Preger C, Bonomi F, et al.
J Autoimmun
. 2024 Nov;
149:103332.
PMID: 39561568
Background: Autoantibodies are found in up to 80 % of patients with idiopathic inflammatory myopathies (IIM) and are associated with distinct clinical phenotypes. Autoantibodies targeting cytosolic 5'-nucleotidase 1A (anti-NT5C1A) are...
2.
Leijding C, Kaewin S, Andreasson K, Horuluoglu B, Galindo-Feria A, Van Gompel E, et al.
Ann Rheum Dis
. 2024 Aug;
83(12):1796-1797.
PMID: 39197873
No abstract available.
3.
Galindo-Feria A, Lodin K, Horuluoglu B, Sarrafzadeh-Zargar S, Wigren E, Graslund S, et al.
Rheumatology (Oxford)
. 2024 Jun;
64(3):1482-1492.
PMID: 38833674
Objectives: To determine prevalence and clinical associations of anti-Four-and-a-half-LIM-domain 1 (FHL1) autoantibodies in patients with idiopathic inflammatory myopathies (IIM) and to evaluate autoantibody levels over time. Methods: Sera at the...
4.
Van Gompel E, Demirdal D, Fernandes-Cerqueira C, Horuluoglu B, Galindo-Feria A, Wigren E, et al.
Rheumatology (Oxford)
. 2023 Aug;
63(5):1466-1473.
PMID: 37572295
Objectives: Clinical observations in patients with dermatomyositis (DM) and autoantibodies against the melanoma differentiation-associated protein 5 (MDA5) suggest that the autoantibodies contribute to the pathogenesis of MDA5(+) DM. To gain...
5.
Argyriou A, Horuluoglu B, Galindo-Feria A, Diaz-Boada J, Sijbranda M, Notarnicola A, et al.
EMBO Mol Med
. 2023 Jul;
15(10):e17240.
PMID: 37522383
Idiopathic inflammatory myopathies (IIM) are rare autoimmune systemic diseases characterized by muscle weakness and the presence of muscle-infiltrating T cells. IIM represent a clinical challenge due to heterogeneity of symptoms...
6.
Lundberg I, Galindo-Feria A, Horuluoglu B
JAMA
. 2023 Jun;
329(24):2130-2131.
PMID: 37367988
No abstract available.
7.
Hensvold A, Horuluoglu B, Sahlstrom P, Thyagarajan R, Diaz Boada J, Hansson M, et al.
J Autoimmun
. 2023 Mar;
136:103022.
PMID: 37001434
A majority of circulating IgG is produced by plasma cells residing in the bone marrow (BM). Long-lived BM plasma cells constitute our humoral immune memory and are essential for infection-specific...
8.
Sharma R, Yoosuf N, Afonso M, Scheffschick A, Avik A, Bartoletti A, et al.
Kidney Int
. 2023 Feb;
103(5):973-985.
PMID: 36804380
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune disease involving autoreactivity to proteinase 3 (PR3) as demonstrated by presence of ANCAs. While autoantibodies are screened for diagnosis, autoreactive T...
9.
Galindo-Feria A, Notarnicola A, Lundberg I, Horuluoglu B
Front Immunol
. 2022 May;
13:866087.
PMID: 35634293
Anti-synthetase syndrome (ASSD) is an autoimmune disease characterized by the presence of autoantibodies targeting one of several aminoacyl t-RNA synthetases (aaRSs) along with clinical features including interstitial lung disease, myositis,...
10.
Galindo-Feria A, Horuluoglu B, Day J, Fernandes-Cerqueira C, Wigren E, Graslund S, et al.
Rheumatology (Oxford)
. 2022 Jan;
61(10):4145-4154.
PMID: 35022656
Objectives: To determine the prevalence and associations of autoantibodies targeting a muscle-specific autoantigen, four-and-a-half-LIM-domain 1 (FHL1), in South Australian patients with histologically-confirmed idiopathic inflammatory myopathies (IIM) and in patients with...